DualVis Dosage & Drug Information

Concise Prescribing Info Bahasa Concise Prescribing Info

Concise Prescribing Info

Contents

Na hyaluronate (0.7 mL of 2.2% low-molecular wt (LMW) Na hyaluronate + 0.7 mL of 1% high-molecular wt (HMW) Na hyaluronate)

Indications/Uses

Relief of symptoms of knee OA grade 1-3 medial compartment.

Dosage/Direction for Use

1.4 mL (LMW + HMW) inj into knee joint on 1st day followed by a 2nd inj 1 wk after.

Contraindications

Known sensitivity to Na hyaluronate. Infection or evidence of skin disease at inj site. Childn.

Adverse Reactions

Inflammatory reaction (rarely).

View ADR Monitoring Form

MIMS Class

ATC Classification

M09AX01 - hyaluronic acid ; Belongs to the class of other drugs for disorders of the musculo-skeletal system.

Regulatory Classification

Presentation/Packing

Form

DualVis pre-filled syringe

Packing/Price

(2-chamber) 1.4 mL x 1's

DualVis